Nine Masts Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Nine Masts Capital's PFE Position: Q3 2026 in Review
Nine Masts Capital sold out of Pfizer (PFE) in Q3 2026, closing a stake of 68,200 shares — an estimated $1.64M sold.
Nine Masts Capital first reported a position in PFE in Q2 2017 and held it in 4 quarters. The position peaked at $1.64M in Q2 2026. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Nine Masts Capital reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- Nine Masts Capital sold 68,200 Pfizer shares in Q3 2026, an estimated $1.64M.
- Nine Masts Capital first reported a position in Pfizer in Q2 2017 and held it in 4 quarters.
- Nine Masts Capital's Pfizer position peaked at $1.64M in Q2 2026.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Nine Masts Capital's 13F filing for Q3 2026, filed 9 Nov 2026.